Italian pharmaceutical industry goes like a Ferrari of the best times - survey by Doxa Pharma: research, innovation, welfare and top investments

Italian pharmaceutical industry goes like a Ferrari of the best times - survey by Doxa Pharma: research, innovation, welfare and top investments

(by Nicola Simonetti) Italian pharmaceutical industry on shields in Europe. "It goes like a Ferrari of the best times and grows in the general reputation that - said Giuseppe Venturelli, of Doxa Pharma at the meeting organized by Abbvie, a global biopharmaceutical company based on research that has invested in production in recent years, 130 million euro - since 73,5% has passed to 73,8%.

Reputation is a one-to-one relationship at the base of which there is a promise kept, collaboration correctness, clarity, availability always renewed and confirmed.

Pharmaceutical production helps the Italian economy in times of difficulty.

In Italy - continues Venturelli - this industry makes investments that represent twice as many as in all other European countries and, this year, is growing by 7%.

The GDP from the 2008 to the 2018 has exceeded the 22% and, in the 2019 has grown by 3,2 per cent. The investment in innovation has also doubled, compared to Europe, in the 2018, and further increased by 7 per cent.

The entire health chain, the 10,7%, of which the pharmaceutical production alone represents 1,8%.

Italy is the first pharmaceutical manufacturing country in Europe and the third largest industry in the country where the value of pharmaceutical production in 2018 was 32 billion.

Italy, first also in the pharmaceutical export that sees a growth of 117% (in 2019 + 15%, the highest in Europe).

The pharmaceutical industry is standard-bearer in employment growth, especially in production and research, thanks also to 7.000 recruitment per year (50% young people).

The occupation between the 2014 and the 2018 records an increase in 8,7% where the average in the manufacturing industry stops at 2%.

Support also for youth employment: more 8,7% between the 2014 and the 2018. The average of the 35 under is 20%.

The woman-man ratio is also correct as women represent the 42% with medium-high grades.

Innovation comes with certified quality, cutting-edge technology (the Abbivie production center in Campoverde in Aprilia stands as an example at the top of the ranking: 270 thousand square meters with cutting-edge product training and packaging plants, 2 chemical plants, production of active ingredients with export of more than 80% of its production).

Pharmaceutical production - concludes Venturelli who was based on the data of a survey carried out by Doxa Pharma - is anti-cyclical and driven both for itself and for the related industries, it produces skilled jobs, it is above any gender discrimination age and his reputation has soared over the past three years. Respect for ecology and the environment is scrupulously applied as in Campoverde where there is a reduction of over 50% of groundwater use, self-production of about 90% of energy needs, zero waste sent. in landfills and over 85% destined for recycling.

In the front row, in Europe, from the 2008 to the 2018, for the export which, moreover, in the 2019 has totaled the 15% more confirming its pre-eminence in the field of the EU.

Employment sees over 40.000 production workers, from the 2014 to the 2018, thanks to 7.000 assumptions, of which the 50% with 8,7% increase when the manufacturing average stops at 2%.

The pharmaceutical industry - it must be reiterated - is ° the segment that, in Italy, employs the most young people and, in particular, the under 35s.

The health sector is the third largest industry in the country and accounts for 10,7% of GDP. The pharmaceutical sector generates 32 billion in value and a growth of 22% in 10 years, the highest in Italy. As the analysis conducted by Doxapharma points out, the pharmaceutical industry - Venturelli emphasizes - is increasingly popular with Italians thanks to research, innovation, welfare and investments. A leading sector in Europe in terms of exports and which employs over 66 employees, 90% of whom are graduates and graduates, with an increase of around 7 skilled places a year.

Italian pharmaceutical industry goes like a Ferrari of the best times - survey by Doxa Pharma: research, innovation, welfare and top investments